Literature DB >> 21255581

Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling.

Kimberlee M Fischer1, Christopher T Cottage, Mathias H Konstandin, Mirko Völkers, Mohsin Khan, Mark A Sussman.   

Abstract

Stem cells mediate tissue repair throughout the lifespan of an organism. However, the ability of stem cells to mitigate catastrophic damage, such as that sustained after major myocardial infarction is inadequate to rebuild the heart and restore functional capacity. However, capitalizing on the ability of these cells to attenuate damage in the myocardium, various maneuvers that enhance repair mechanisms to improve cardiac structure and function after injury are being investigated. These studies have led to discovery of various factors that mediate cardioprotection and enhance endogenous repair by 1) salvaging surviving myocardium, 2) promoting homing of stem cells and 3) increasing survival and proliferation of stem cell populations at the site of injury. Herein we report upon a downstream target of Akt kinase, named Pim-1, which promotes cardioprotective signaling and enhances cardiac structure and function after pathological injury. The compilation of studies presented here supports use of Pim-1 to enhance long-term myocardial repair after pathological damage. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255581      PMCID: PMC3130822          DOI: 10.1016/j.yjmcc.2011.01.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  38 in total

Review 1.  The survival kinases Akt and Pim as potential pharmacological targets.

Authors:  Ravi Amaravadi; Craig B Thompson
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.

Authors:  Malte Bachmann; Christian Kosan; Pei Xiang Xing; Mathias Montenarh; Ingrid Hoffmann; Tarik Möröy
Journal:  Int J Biochem Cell Biol       Date:  2005-11-08       Impact factor: 5.085

3.  The human PIM-1 gene product is a protein serine kinase.

Authors:  R Padma; L Nagarajan
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

4.  The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.

Authors:  M Lilly; J Sandholm; J J Cooper; P J Koskinen; A Kraft
Journal:  Oncogene       Date:  1999-07-08       Impact factor: 9.867

5.  Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection.

Authors:  T Schmidt; H Karsunky; B Rödel; B Zevnik; H P Elsässer; T Möröy
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

6.  Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase.

Authors:  Kevin C Qian; Lian Wang; Eugene R Hickey; Joey Studts; Kevin Barringer; Charline Peng; Anthony Kronkaitis; Jun Li; Andre White; Sheenah Mische; Bennett Farmer
Journal:  J Biol Chem       Date:  2004-11-03       Impact factor: 5.157

7.  Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway.

Authors:  T Mochizuki; C Kitanaka; K Noguchi; T Muramatsu; A Asai; Y Kuchino
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

Review 8.  The serine/threonine kinase Pim-1.

Authors:  Malte Bachmann; Tarik Möröy
Journal:  Int J Biochem Cell Biol       Date:  2005-04       Impact factor: 5.085

9.  Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase.

Authors:  C K Palaty; G Kalmar; G Tai; S Oh; L Amankawa; M Affolter; R Aebersold; S L Pelech
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

10.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

Authors:  R Amson; F Sigaux; S Przedborski; G Flandrin; D Givol; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

View more
  18 in total

1.  Decline in cellular function of aged mouse c-kit+ cardiac progenitor cells.

Authors:  Alessandra Castaldi; Ramsinh Mansinh Dodia; Amabel M Orogo; Cristina M Zambrano; Rita H Najor; Åsa B Gustafsson; Joan Heller Brown; Nicole H Purcell
Journal:  J Physiol       Date:  2017-08-18       Impact factor: 5.182

Review 2.  PIM kinase (and Akt) biology and signaling in tumors.

Authors:  Noel A Warfel; Andrew S Kraft
Journal:  Pharmacol Ther       Date:  2015-03-05       Impact factor: 12.310

Review 3.  Empowering adult stem cells for myocardial regeneration.

Authors:  Sadia Mohsin; Sailay Siddiqi; Brett Collins; Mark A Sussman
Journal:  Circ Res       Date:  2011-12-09       Impact factor: 17.367

4.  Cardiac progenitor cells engineered with Pim-1 (CPCeP) develop cardiac phenotypic electrophysiological properties as they are co-cultured with neonatal myocytes.

Authors:  Hale Tufan; Xiao-Hua Zhang; Nicole Haghshenas; Mark A Sussman; Lars Cleemann; Martin Morad
Journal:  J Mol Cell Cardiol       Date:  2012-08-19       Impact factor: 5.000

5.  Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs.

Authors:  Alessandra Castaldi; Gino P Chesini; Amy E Taylor; Mark A Sussman; Joan Heller Brown; Nicole H Purcell
Journal:  Cell Signal       Date:  2016-04-14       Impact factor: 4.315

Review 6.  Cardiac stem cells: biology and clinical applications.

Authors:  Polina Goichberg; Jerway Chang; Ronglih Liao; Annarosa Leri
Journal:  Antioxid Redox Signal       Date:  2014-04-10       Impact factor: 8.401

7.  Metabolic dysfunction consistent with premature aging results from deletion of Pim kinases.

Authors:  Shabana Din; Mathias H Konstandin; Bevan Johnson; Jacqueline Emathinger; Mirko Völkers; Haruhiro Toko; Brett Collins; Lucy Ormachea; Kaitlen Samse; Dieter A Kubli; Andrea De La Torre; Andrew S Kraft; Asa B Gustafsson; Daniel P Kelly; Mark A Sussman
Journal:  Circ Res       Date:  2014-06-10       Impact factor: 17.367

Review 8.  Novel Biological Therapies Targeting Heart Failure: Myocardial Rejuvenation.

Authors:  Amanda J Favreau-Lessard; Sergey Ryzhov; Douglas B Sawyer
Journal:  Heart Fail Clin       Date:  2016-05-10       Impact factor: 3.179

9.  Cardiac c-Kit Biology Revealed by Inducible Transgenesis.

Authors:  Natalie A Gude; Fareheh Firouzi; Kathleen M Broughton; Kelli Ilves; Kristine P Nguyen; Christina R Payne; Veronica Sacchi; Megan M Monsanto; Alexandria R Casillas; Farid G Khalafalla; Bingyan J Wang; David E Ebeid; Roberto Alvarez; Walter P Dembitsky; Barbara A Bailey; Jop van Berlo; Mark A Sussman
Journal:  Circ Res       Date:  2018-04-10       Impact factor: 17.367

Review 10.  Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.

Authors:  David A Kass
Journal:  Curr Heart Fail Rep       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.